A platform that uses multiple immune B-cell sources and discovery pathways to generate diverse, high-affinity antibodies rapidly for therapeutic, diagnostic, and reagent development.

Services for discovering and developing non-traditional antibody formats including single-chain antibodies, single-domain antibodies, ADCs, chimeric antibodies, T-cell therapies, and bispecific antibodies.